Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal L Oden

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Controlled Clinical Trials|February 1, 2003
Statistical issues related to early closure of STOP-ROP, a group-sequential trialNeal L Oden, Dale L Phelps,
Human Biology|March 26, 2013
A problem with synthetic maps. 1999Robert R Sokal, Neal L Oden, Barbara A Thomson
American Journal of Human Biology : the Official Journal of the Human Biology Council|June 1, 2017
The patterns of historical population movements in Europe and some of their genetic consequencesRobert R Sokal, Neal L Oden, Michael S Rosenberg, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|December 23, 2003
A new protocol for evaluating putative causes for multiple variables in a spatial setting, illustrated by its application to European cancer ratesRobert R Sokal, Neal L Oden, Michael S Rosenberg, et al.
Paediatric and Perinatal Epidemiology|August 2, 2006
Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurityRolf R Engel, Neal L Oden, Geoff R Cohen, et al.
Human Biology|March 26, 2013
Historical population movements in Europe influence genetic relationships in modern samples. 1996Robert R Sokal, Neal L Oden, Jeff Walker, et al.
American Journal of Ophthalmology|April 24, 2022
Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein OcclusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
American Journal of Ophthalmology|December 7, 2023
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein OcclusionMichael S Ip, Ingrid U Scott, Paul C VanVeldhuisen, et al.
American Journal of Ophthalmology|December 30, 2022
SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness OutcomesIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
Ophthalmology|April 4, 2024
ReplyIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Controlled Clinical Trials|February 1, 2003
Statistical issues related to early closure of STOP-ROP, a group-sequential trialNeal L Oden, Dale L Phelps,
Human Biology|March 26, 2013
A problem with synthetic maps. 1999Robert R Sokal, Neal L Oden, Barbara A Thomson
American Journal of Human Biology : the Official Journal of the Human Biology Council|June 1, 2017
The patterns of historical population movements in Europe and some of their genetic consequencesRobert R Sokal, Neal L Oden, Michael S Rosenberg, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|December 23, 2003
A new protocol for evaluating putative causes for multiple variables in a spatial setting, illustrated by its application to European cancer ratesRobert R Sokal, Neal L Oden, Michael S Rosenberg, et al.
Paediatric and Perinatal Epidemiology|August 2, 2006
Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurityRolf R Engel, Neal L Oden, Geoff R Cohen, et al.
Human Biology|March 26, 2013
Historical population movements in Europe influence genetic relationships in modern samples. 1996Robert R Sokal, Neal L Oden, Jeff Walker, et al.
American Journal of Ophthalmology|April 24, 2022
Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein OcclusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
American Journal of Ophthalmology|December 7, 2023
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein OcclusionMichael S Ip, Ingrid U Scott, Paul C VanVeldhuisen, et al.
American Journal of Ophthalmology|December 30, 2022
SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness OutcomesIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
Ophthalmology|April 4, 2024
ReplyIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
Pageof 6